Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.